<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mmd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mmd</book-part-id>
      <title-group>
        <title>Multiminicore Disease</title>
        <alt-title alt-title-type="alt-title">Synonyms: Minicore Disease, Minicore Myopathy, Multicore Disease, Multicore Myopathy, Multiminicore Myopathy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Beggs</surname>
            <given-names>Alan H</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Program in Genomics and Division of Genetics<break/>Boston Children's Hospital <break/>Harvard Medical School<break/>Boston, Massachusetts</aff>
          <email>beggs@enders.tch.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Agrawal</surname>
            <given-names>Pankaj B</given-names>
          </name>
          <degrees>MD, MMSc</degrees>
          <aff>Program in Genomics and Division of Genetics<break/>Boston Children's Hospital <break/>Harvard Medical School<break/>Boston, Massachusetts</aff>
          <email>pankaj.agrawal@tch.harvard.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>25</day>
          <month>3</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>24</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mona" document-type="chapter">Multicentric Osteolysis Nodulosis and Arthropathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="vmcm" document-type="chapter">Multiple Cutaneous and Mucosal Venous Malformations</related-object>
      <abstract id="mmd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Multiminicore disease (MmD) is broadly classified into four groups:</p>
          <list list-type="bullet">
            <list-item>
              <p>Classic form (75% of individuals)</p>
            </list-item>
            <list-item>
              <p>Moderate form, with hand involvement (&#x0003c;10%)</p>
            </list-item>
            <list-item>
              <p>Antenatal form, with arthrogryposis multiplex congenita (&#x0003c;10%)</p>
            </list-item>
            <list-item>
              <p>Ophthalmoplegic form (&#x0003c;10%)</p>
            </list-item>
          </list>
          <p>Onset of the classic form is usually congenital or early in childhood with neonatal hypotonia, delayed motor development, axial muscle weakness, scoliosis, and significant respiratory involvement (often with secondary cardiac impairment). Spinal rigidity of varying severity is present.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of MmD is based on the presence of multiple "minicores" visible on muscle biopsy using oxidative stains, clinical findings of static or slowly progressive weakness, and absence of findings diagnostic of other neuromuscular disorders. Pathogenic variants in <italic toggle="yes">SELENON</italic> (<italic toggle="yes">SEPN1</italic>) and <italic toggle="yes">RYR1</italic> are known to cause 50% of MmD cases reported; further genetic heterogeneity is suggested, but no other candidate region or gene has been identified to date.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Respiratory support as needed; aggressive treatment of lower respiratory infections; nasogastric feeding and high caloric density formulas as needed; physical and occupational therapy to improve/maintain gross and fine motor function and reduce joint contractures; speech therapy as needed; orthopedic treatment of scoliosis.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Yearly influenza and other respiratory infection-related immunizations.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine evaluations of: neuromuscular status to assess disease progression; respiratory function re the risk of insidious nocturnal hypoxia and sudden respiratory failure; cardiac status re the risk of cardiac impairment secondary to respiratory involvement; the spine for scoliosis particularly during childhood and adolescence.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Depolarizing muscle relaxants and inhalational agents during surgery or childbirth, as they can trigger malignant hyperthermia.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>MmD is most often inherited in an autosomal recessive manner. The occurrence of MMD in two generations in a few families has been reported, suggestive of autosomal dominant inheritance. Assuming autosomal recessive inheritance, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mmd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mmd.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Multiminicore disease (MmD) has a wide clinical spectrum with four distinct phenotypes (see <xref ref-type="sec" rid="mmd.Clinical_Characteristics">Clinical Description</xref>). Clinical findings that may support the diagnosis of MmD include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Weakness</bold> (predominantly axial and proximal) and hypotonia; scoliosis and respiratory difficulty occur in approximately two-thirds of affected individuals.</p>
            </list-item>
            <list-item>
              <p><bold>Onset</bold> typically at birth or during infancy; sometimes in childhood</p>
            </list-item>
          </list>
        </sec>
        <sec id="mmd.Testing">
          <title>Testing</title>
          <sec id="mmd.Muscle_Biopsy">
            <title>Muscle Biopsy</title>
            <p>The diagnosis of MmD is based on the presence of multiple "minicores," small zones of sarcomeric disorganization and/or diminished oxidative activity that correlate with lack of mitochondria in muscle fibers. Unlike the cores typical of <related-object link-type="booklink" source-id="gene" document-id="cco" document-type="chapter">central core disease</related-object>, minicores affect both type I and type II fibers and are short in length, spanning only a few sarcomeres in the fiber longitudinal axis.</p>
            <p>Note: Because minicores are not specific to MmD, the diagnosis of MmD is based on the presence of minicores in a large proportion of muscle fibers associated with static or slowly progressive weakness and absence of findings diagnostic of other disorders.</p>
            <p><bold>H&#x00026;E staining</bold> reveals moderate to marked variability in fiber size; the number of internal nuclei may be increased. Fat and/or connective tissue is normal or mildly increased. Myofibrillar ATPase staining may be normal, but frequently shows type I fiber predominance. Relative hypotrophy of type I fibers is often observed, with mean diameter of type I fibers smaller than that of type II fibers in many cases.</p>
            <p><bold>Oxidative stains</bold> (NADH-TR, succinate dehydrogenase, cytochrome oxidase) reveal multiple small focal lesions ("minicores") of sarcomeric disorganization and/or reduced or absent oxidative activity in 60%-90% of fibers. These focal lesions are generally round, small, variable in size, multiple, and randomly distributed with poorly defined boundaries. The cores are often oriented transversely to the fibers and may span up to 15 to 20 sarcomeres [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2000.745">Ferreiro et al 2000</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2000.264">Jungbluth et al 2000</xref>]. While cytochrome oxidase staining is specific for lack of mitochondria, NADH-TR staining reveals both the lack of mitochondria and the myofibrillar disruption characteristic of "unstructured cores."</p>
            <p><bold>Immunohistochemistry.</bold> Reliable (but nonspecific) markers for MmD [<xref ref-type="bibr" rid="mmd.REF.fischer.2002.297">Fischer et al 2002</xref>, <xref ref-type="bibr" rid="mmd.REF.b_nnemann.2003.71">B&#x000f6;nnemann et al 2003</xref>] include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Anti-titin antibodies</bold> reveal disorganization of the normal striated pattern in unstructured cores.</p>
              </list-item>
              <list-item>
                <p><bold>Anti-desmin antibodies</bold> show increased reactivity in the core lesions.</p>
              </list-item>
              <list-item>
                <p><bold>AlphaB-crystallin, heat shock protein 27, and filamin C</bold> have shown increased immunoreactivity in core lesions (minicore, central core, and target fibers).</p>
              </list-item>
            </list>
            <p>Anti-alpha-actinin and anti-actin antibodies do not reveal any abnormalities [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2000.745">Ferreiro et al 2000</xref>].</p>
            <p><bold>Electron microscopy.</bold> Cores are typically unstructured and often circular. Their appearance ranges from focal areas of Z line streaming and reduced or absent mitochondria to severe focal disorganization of myofibrillar structure [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2000.745">Ferreiro et al 2000</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2000.264">Jungbluth et al 2000</xref>]. "Structured" minicores, exhibiting intact sarcomeres and only absence of mitochondria, may be more difficult to detect [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2002.60">Ferreiro &#x00026; Fardeau 2002</xref>].</p>
          </sec>
          <sec id="mmd.Biochemical_and_Electrophysiologic_S">
            <title>Biochemical and Electrophysiologic Studies</title>
            <p>Studies may suggest a myopathic process but have a limited role in making the diagnosis.</p>
            <p><bold>Serum creatine kinase concentration</bold> is normal or slightly elevated.</p>
            <p><bold>EMG</bold> ranges from normal to nonspecifically abnormal, with findings such as low-amplitude polyphasic potentials of short duration. The absence of a neurogenic pattern eliminates the possibility of denervation, which may also lead to presence of core lesions.</p>
          </sec>
          <sec id="mmd.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> Pathogenic variants in two genes are known to cause MmD in approximately 50% of affected individuals.</p>
            <p><bold>Evidence for locus heterogeneity.</bold> Further genetic heterogeneity is suggested: a family with dilated cardiomyopathy and multiple minicores and another family with overlapping features of <related-object link-type="booklink" source-id="gene" document-id="mpd1" document-type="chapter">Laing distal myopathy</related-object> and MmD have been described, both with heterozygous <italic toggle="yes">MYH7</italic> pathogenic variants [<xref ref-type="bibr" rid="mmd.REF.cullup.2012.1096">Cullup et al 2012</xref>].</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="mmd.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Multiminicore Disease</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of MmD Attributed to Mutation of This Gene</th>
                    <th id="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">SELENON</italic> (<italic toggle="yes">SEPN1</italic>)</td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">30%-54%&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Unknown</td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">RYR1</italic>
                    </td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Unknown</td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis of select exons&#x000a0;<sup>4,</sup>&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants in select exons</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Unknown</td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_mmd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>5</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mmd.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="mmd" object-id="mmd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="mmd.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="mmd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="mmd.TF.1.3">
                  <label>3. </label>
                  <p>Autosomal recessive <italic toggle="yes">SELENON</italic> pathogenic variants account for approximately 30% of all MmD and approximately 50% of classic MmD [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2002b.739">Ferreiro et al 2002b</xref>]. An estimated 40% of individuals with <italic toggle="yes">SELENON</italic> pathogenic variants are compound heterozygotes.</p>
                </fn>
                <fn id="mmd.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="mmd.TF.1.5">
                  <label>5. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="mmd.TF.1.6">
                  <label>6. </label>
                  <p>No deletions or duplications involving <italic toggle="yes">SELENON</italic> or <italic toggle="yes">RYR1</italic> have been reported to cause multiminicore disease.</p>
                </fn>
                <fn id="mmd.TF.1.7">
                  <label>7. </label>
                  <p>Exons sequenced may vary by laboratory.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v20/n2/full/ejhg2011180a.html">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="mmd.REF.lillis.2012">Lillis et al 2012</xref>] for information on test characteristics including sensitivity and specificity.</p>
          </sec>
        </sec>
        <sec id="mmd.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> MmD is a clinicopathologic entity that requires histopathologic examination of a muscle biopsy for the diagnosis to be made.</p>
          <p>Clinical evaluation includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Personal medical history and physical examination, with particular attention to features of congenital myopathy or muscular dystrophy (e.g., weakness, hypotonia, failure to thrive, scoliosis)</p>
            </list-item>
            <list-item>
              <p>Family history, with particular attention to features of congenital myopathy or muscular dystrophy</p>
            </list-item>
          </list>
          <p>Genetic diagnosis requires molecular genetic testing of <italic toggle="yes">SELENON</italic> and <italic toggle="yes">RYR1</italic>.</p>
          <list list-type="bullet">
            <list-item>
              <p>Because the majority of individuals with MmD have a pathogenic variant in <italic toggle="yes">SELENON</italic>, sequence analysis should be done first.</p>
            </list-item>
            <list-item>
              <p>If no <italic toggle="yes">SELENON</italic> pathogenic variants are identified, sequence analysis of <italic toggle="yes">RYR1</italic> should be considered, particularly for those individuals with non-classic forms of MmD.</p>
            </list-item>
            <list-item>
              <p>Although no deletions or duplications of either <italic toggle="yes">SELENON</italic> or <italic toggle="yes">RYR1</italic> have been reported to date to cause MmD, deletion/duplication analysis of each of these genes could be considered in an individual with features of MmD in whom causative variants in <italic toggle="yes">SELENON</italic> and <italic toggle="yes">RYR1</italic> have not been identified through sequence analysis.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for an autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis</bold>
<bold>and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies requires prior identification of the pathogenic variants in the family.</p>
        </sec>
      </sec>
      <sec id="mmd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mmd.Clinical_Description">
          <title>Clinical Description</title>
          <p>Multiminicore disease (MmD) is characterized by axial and proximal muscle weakness. It is usually slowly progressive; however, fatal cases have been described. High-arched palate and chest deformities are common.</p>
          <p>MmD is broadly classified into four forms [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2000.745">Ferreiro et al 2000</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2000.264">Jungbluth et al 2000</xref>, <xref ref-type="bibr" rid="mmd.REF.ferreiro.2002.60">Ferreiro &#x00026; Fardeau 2002</xref>, <xref ref-type="bibr" rid="mmd.REF.nadajpakleza.2007.56">Nadaj-Pakleza et al 2007</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Classic form</p>
            </list-item>
            <list-item>
              <p>Moderate form, with hand involvement</p>
            </list-item>
            <list-item>
              <p>Antenatal form, with arthrogryposis multiplex congenita</p>
            </list-item>
            <list-item>
              <p>Ophthalmoplegic form</p>
            </list-item>
          </list>
          <p>In all forms, males and females are equally affected.</p>
          <p>
            <bold>Classic MmD (75%)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>
                <bold>Characteristic features</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Onset is usually congenital or occurs in early childhood with neonatal hypotonia and delayed motor development including head lag, a common and early sign.</p>
                </list-item>
                <list-item>
                  <p>Axial muscle weakness leads to development of scoliosis and major respiratory involvement in approximately two thirds of individuals. Scoliosis develops at a mean age of 8.5 years and is generally cervicodorsal and progressive [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2000.745">Ferreiro et al 2000</xref>]. Varying severity of spinal rigidity is present.</p>
                </list-item>
                <list-item>
                  <p>Rigid spine muscular dystrophy (RSMD), characterized by limited flexion of dorsolumbar and cervical spine (caused by contractures of spinal extensor muscles) is now considered a form of classic MmD. The majority of individuals with these findings have <italic toggle="yes">SELENON</italic> pathogenic variants and minicores on muscle biopsy [<xref ref-type="bibr" rid="mmd.REF.moghadaszadeh.2001.17">Moghadaszadeh et al 2001</xref>, <xref ref-type="bibr" rid="mmd.REF.ferreiro.2002b.739">Ferreiro et al 2002b</xref>].</p>
                </list-item>
                <list-item>
                  <p>Strength of trunk and neck flexors is usually scored 1 to 2 out of 5, pelvic and shoulder girdle muscles 3 to 4, and distal muscles normal or only moderately weak (3+ to 5). Individuals are usually ambulatory, as limb muscle strength is relatively preserved.</p>
                </list-item>
                <list-item>
                  <p>Facial muscle strength ranges from normal to severe weakness; extraocular muscles are spared.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Cardiac.</bold> Cardiac involvement (right ventricular failure, cardiomyopathy) secondary to respiratory impairment is common. Mitral valve prolapse is occasionally seen.</p>
            </list-item>
            <list-item>
              <p><bold>Other features.</bold> Most individuals have short stature and failure to thrive. Some individuals are slender and have a marfanoid habitus but no other features of <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>Course.</bold> Scoliosis is progressive and associated with loss of respiratory function in mid-later childhood, after which the course is often static.</p>
              <p>Individuals may walk well into adulthood despite severe scoliosis and need for ventilatory support. In a few severe cases the disease may progress slowly through adolescence and adulthood, eventually leading to loss of ambulation.</p>
              <p>Death often occurs as a result of respiratory infection in a setting of severe respiratory insufficiency.</p>
              <p>Late onset of the disease is usually associated with better prognosis.</p>
            </list-item>
          </list>
          <p><bold>Moderate form with hand involvement (&#x0003c;10%).</bold> The characteristic feature is distal weakness of the upper limbs with joint hyperlaxity. Distal lower limbs are relatively normal. Scoliosis and respiratory involvement are mild or absent.</p>
          <p><bold>Antenatal form with arthrogryposis multiplex congenita (AMC) (&#x0003c;10%).</bold> The characteristic feature is generalized joint contractures at birth as a result of poor fetal movement. Associated distinctive features are dolicocephaly, prominent nasal root, oblique palpebral fissues, high-arched palate, low-set ears, short neck, and clinodactyly.</p>
          <p><bold>Ophthalmoplegic form (&#x0003c;10%)</bold> usually presents in the neonatal period or early infancy with marked generalized hypotonia and weakness. Failure to thrive and pronounced weakness of the axial and proximal muscles are common. External ophthalmoplegia predominantly affects upward and lateral gaze. Ligaments are universally lax. Respiratory function is moderately impaired but nocturnal hypoventilation is usually not a finding [<xref ref-type="bibr" rid="mmd.REF.jungbluth.2000.264">Jungbluth et al 2000</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2005.1930">Jungbluth et al 2005</xref>].</p>
        </sec>
        <sec id="mmd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold><italic toggle="yes">SELENON</italic> (<italic toggle="yes">SEPN1</italic>)<italic toggle="yes">.</italic></bold> Individuals with <italic toggle="yes">SELENON</italic> pathogenic variants have classic MmD. May develop early and severe scoliosis resulting in respiratory insufficiency requiring respiratory assistance [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2002b.739">Ferreiro et al 2002b</xref>].</p>
          <p><bold><italic toggle="yes">RYR1.</italic></bold> The disease is usually milder than that caused by mutation of <italic toggle="yes">SELENON</italic>. The forms of MmD associated with <italic toggle="yes">RYR1</italic> pathogenic variants include the moderate form with hand involvement [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2002a.750">Ferreiro et al 2002a</xref>] and the ophthalmoplegic form [<xref ref-type="bibr" rid="mmd.REF.monnier.2003.1171">Monnier et al 2003</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2005.1930">Jungbluth et al 2005</xref>].</p>
        </sec>
        <sec id="mmd.Nomenclature">
          <title>Nomenclature</title>
          <p>Rigid spine muscular dystrophy or rigid spine syndrome are now considered the same entity as severe classic MmD.</p>
        </sec>
        <sec id="mmd.Prevalence">
          <title>Prevalence</title>
          <p>MmD is thought to be rare. Actual prevalence figures are unknown. The disease occurs in diverse ethnic and racial groups.</p>
        </sec>
      </sec>
      <sec id="mmd.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <sec id="mmd.SELENON_SEPN1">
          <title><italic toggle="yes">SELENON</italic> (<italic toggle="yes">SEPN1</italic>)</title>
          <p><related-object link-type="booklink" source-id="gene" document-id="cftd" document-type="chapter"><bold>Congenital fiber-type disproportion</bold></related-object>
<bold>(CFTD)</bold> is a type of congenital myopathy characterized by hypotonia and mild-to-severe generalized muscle weakness at birth or within the first year of life. The diagnosis is made on muscle biopsy showing type 1 fibers that are at least 12% smaller than the mean diameter of type 2A and/or type 2B fibers in the absence of other significant pathologic findings (e.g., nemaline bodies, cores, or central nuclei).</p>
          <p>In a recent study [<xref ref-type="bibr" rid="mmd.REF.clarke.2006.546">Clarke et al 2006</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Two sibs with CFTD homozygous for a <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">c.943G&#x0003e;A</inline-supplementary-material> pathogenic variant in <italic toggle="yes">SELENON</italic> had clinical findings similar to those of <italic toggle="yes">SELENON</italic>-related myopathy.</p>
            </list-item>
            <list-item>
              <p>Three women in one family who were homozygous for the c.943G&#x0003e;A pathogenic variant had similar clinical findings. Only one had a muscle biopsy; it revealed type 1 fibers to be 10.5% smaller than type 2 fibers (for the diagnosis of CFTD, the type 1 fibers should be &#x0003e;12% smaller), consistent with nonspecific myopathy. No histopathologic features of MmD, RSMD, or desmin-related myopathy were found.</p>
            </list-item>
          </list>
          <p>It is important to remember that a few cases of CFTD and <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">centronuclear myopathy</related-object> may show features consistent with MmD on ultrastructural examination [<xref ref-type="bibr" rid="mmd.REF.nadajpakleza.2007.56">Nadaj-Pakleza et al 2007</xref>].</p>
          <p><bold>Desminopathy.</bold>
<italic toggle="yes">SELENON</italic> pathogenic variants have been identified in individuals with desmin-related myopathy with Mallory body-like inclusions [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2004.676">Ferreiro et al 2004</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="mfm" document-type="chapter">Myofibrillar Myopathy</related-object>). The clinical presentation is similar to that of MmD/RSMD; on muscle biopsy, hyaline plaques that are devoid of any NADH/SDH activity are seen in up to 10% of fibers under light microscopy. Ultrastructurally, these represent intramyofibrillar inclusions arranged in bundles composed of helical filaments 10-12 nm in diameter and surrounded by electron-dense amorphous material.</p>
        </sec>
        <sec id="mmd.RYR1">
          <title>
            <italic toggle="yes">RYR1</italic>
          </title>
          <p><related-object link-type="booklink" source-id="gene" document-id="cco" document-type="chapter"><bold>Central core disease</bold></related-object>
<bold>(CCD)</bold> is most often caused by autosomal dominant pathogenic variants in <italic toggle="yes">RYR1</italic>. The majority of CCD-causing variants are located in the C-terminal region (last 15 exons), which contributes to the formation of the Ca<sup>2+</sup> (calcium)-conducting pore [<xref ref-type="bibr" rid="mmd.REF.monnier.2001.2581">Monnier et al 2001</xref>, <xref ref-type="bibr" rid="mmd.REF.wu.2006.1470">Wu et al 2006</xref>]. Significant clinical and pathologic overlap between CCD and MmD has been identified in individuals who have homozygous or compound heterozygous pathogenic variants in <italic toggle="yes">RYR1</italic>:</p>
          <list list-type="bullet">
            <list-item>
              <p>One family in whom muscle fibers showed coexistence of minicores, central cores, and a few rod-like structures had a homozygous <italic toggle="yes">RYR1</italic> pathogenic variant in exon 101 [<xref ref-type="bibr" rid="mmd.REF.jungbluth.2002.284">Jungbluth et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Another family homozygous for an <italic toggle="yes">RYR1</italic> pathogenic variant in exon 71 had three affected children with a moderate form of minicore disease with hand involvement. Initial biopsy results for this family were consistent with MmD but subsequent biopsy showed progression to lesions typical of CCD [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2002a.750">Ferreiro et al 2002a</xref>].</p>
            </list-item>
            <list-item>
              <p>Ten individuals in whom muscle biopsy revealed significant overlap between central cores and minicores were identified to carry compound heterozygous <italic toggle="yes">RYR1</italic> pathogenic variants distributed throughout the gene. Nine of these ten affected individuals had opthalmoplegia [<xref ref-type="bibr" rid="mmd.REF.monnier.2008.670">Monnier et al 2008</xref>].</p>
            </list-item>
          </list>
          <p><related-object link-type="booklink" source-id="gene" document-id="mhs" document-type="chapter"><bold>Malignant hyperthermia susceptibility</bold></related-object>
<bold>(MHS)</bold> is caused by <italic toggle="yes">RYR1</italic> pathogenic variants predominantly in the N-terminal region of the gene, affecting the cytoplasmic domain of the protein that possibly interacts with dihydropyridine receptor. Approximately 50% of all reported MHS is caused by <italic toggle="yes">RYR1</italic> pathogenic variants. Malignant hyperthermia is also associated with pathogenic variants affecting the central domain and more recently the <italic toggle="yes">RYR1</italic> C-terminal region [<xref ref-type="bibr" rid="mmd.REF.galli.2002">Galli et al 2002</xref>]. Multiple minicores have been described in a small proportion of individuals with MHS (2.6%; n=534) [<xref ref-type="bibr" rid="mmd.REF.guis.2004.106">Guis et al 2004</xref>]. This study also reported a large family of 17 people with MHS, 16 of whom had multiminicores in muscle fiber and two missense variants of <italic toggle="yes">RYR1</italic> on the same allele in exons 50 and 53.</p>
          <p><bold>CFTD</bold> resulting from biallelic <italic toggle="yes">RYR1</italic> pathogenic variants has been identified by a recent study [<xref ref-type="bibr" rid="mmd.REF.clarke.2010.e1544">Clarke et al 2010</xref>]. <italic toggle="yes">RYR1</italic> variants were responsible for 10%-20% of the individuals with CFTD, making this the second most common cause (after <italic toggle="yes">TPM3</italic>). Individuals with CFTD who have ophthalmoplegia are more likely to have <italic toggle="yes">RYR1</italic> pathogenic variants. Reduced ryanodine channel activity as a result of low protein expression has been postulated in some patients with recessive <italic toggle="yes">RYR1</italic> pathogenic variants [<xref ref-type="bibr" rid="mmd.REF.monnier.2008.670">Monnier et al 2008</xref>]; however, the mechanism for type I fiber hypotrophy associated with CFTD is unknown.</p>
          <p><bold>Centronuclear myopathy (CNM).</bold> Pathogenic variants in <italic toggle="yes">RYR1</italic> have been recently identified as a common cause of CNM, further expanding the disease spectrum resulting from mutation of <italic toggle="yes">RYR1</italic> [<xref ref-type="bibr" rid="mmd.REF.wilmshurst.2010.717">Wilmshurst et al 2010</xref>]. While the majority of pathogenic variants were present as compound heterozygous changes, the detection of only a single <italic toggle="yes">RYR1</italic> pathogenic variant inherited from an asymptomatic parent was found in a few families, which could represent either monoallelic <italic toggle="yes">RYR1</italic> expression or missed promoter variants/copy number variations in the second allele. Disease severity in individuals with CNM who have either single or homozygous/compound heterozygous <italic toggle="yes">RYR1</italic> pathogenic variants is extremely variable, and like CFTD and core myopathies, opthalmoplegia is a common finding.</p>
          <p>A missense <italic toggle="yes">RYR1</italic> variant was reported with dominant congenital myopathy in a family with both nemaline bodies and cores [<xref ref-type="bibr" rid="mmd.REF.scacheri.2000.1689">Scacheri et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="mmd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>All forms of congenital myopathy have a number of common clinical features: generalized proximal weakness, hypotonia, hyporeflexia, poor muscle bulk, and features secondary to myopathy (e.g., elongated facies, high arched palate, pectus carinatum, scoliosis, foot deformities). Presence of severe rapidly progressive scoliosis favors a diagnosis of classic multiminicore disease (MmD); however, marked clinical overlap exists among MmD and congenital myopathies as well as other neuromuscular disorders including <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">congenital muscular dystrophy</related-object>. Therefore, the diagnosis of MmD rests on the presence of typical structural changes on muscle biopsy.</p>
        <p>Minicore lesions can coexist with central cores, rods or centrally located nuclei, and variable fibrosis. The differential diagnosis in those cases can include <related-object link-type="booklink" source-id="gene" document-id="cco" document-type="chapter">central core disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="nem" document-type="chapter">nemaline myopathy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">centronuclear myopathy</related-object>, or one of the <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">muscular dystrophies</related-object>. Of these conditions, central core disease is most difficult to differentiate because minicores may be the predominant histopathologic finding in central core disease. In this situation, presence of pronounced hip girdle weakness, only mild facial involvement, lack of significant respiratory impairment, and myalgias or muscle cramps may support a diagnosis of central core disease. Central cores in central core disease have sharply defined boundaries, involve exclusively type I fibers, and extend throughout the entire fiber length, often centrally. However, it is important to remember that the differentiation between minicores and central cores is not always straightforward, and a continuum of histopathologic changes may be present in individuals.</p>
        <p>Dominant pathogenic variants in <italic toggle="yes">ACTA1</italic> have been described in individuals with congenital myopathy with atypical cores (not typical of central cores or multiple minicores) and those with coexisting cores and nemaline rods [<xref ref-type="bibr" rid="mmd.REF.jungbluth.2001.35">Jungbluth et al 2001</xref>, <xref ref-type="bibr" rid="mmd.REF.kaindl.2004.842">Kaindl et al 2004</xref>]. Nemaline bodies with cores have been described in a family with recessive <italic toggle="yes">CFL2</italic> pathogenic variant [<xref ref-type="bibr" rid="mmd.REF.agrawal.2007.162">Agrawal et al 2007</xref>]. Similarly, a locus on chromosome 15q21-q23 has been linked to a dominantly inherited nemaline myopathy with core-like lesions [<xref ref-type="bibr" rid="mmd.REF.gommans.2003.1545">Gommans et al 2003</xref>].</p>
        <p><bold>Secondary MmD.</bold> Multiple minicore lesions can also be secondary to other conditions including <related-object link-type="booklink" source-id="gene" document-id="scad" document-type="chapter">SCAD (short-chain acyl-COA dehydrogenase) deficiency</related-object>, multiple pterygium syndrome with hypertrophic cardiomyopathy, other cardiomyopathies, <related-object link-type="booklink" source-id="gene" document-id="x-hed" document-type="chapter">hypohidrotic ectodermal dysplasia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>, anesthetic reaction, and neurogenic conditions including denervation.</p>
      </sec>
      <sec id="mmd.Management">
        <title>Management</title>
        <sec id="mmd.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with multiminicore disease (MmD), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Comprehensive respiratory evaluation including assessment of breathing rate, signs of respiratory distress, ability to maintain oxygen saturations, pulmonary function studies, and sleep studies to rule out nocturnal hypoxia</p>
            </list-item>
            <list-item>
              <p>Assessment of feeding abilities including suck, swallow, gastroesophageal reflux, and maintenance of airway while feeding; evaluation of growth parameters to identify failure to thrive and determine need for interventions including gavage feeds and gastrostomy tube insertion</p>
            </list-item>
            <list-item>
              <p>Spinal x-rays to evaluate for presence of scoliosis; physical examination for joint contractures</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation for cardiomyopathy/cardiac involvement secondary to respiratory complications</p>
            </list-item>
            <list-item>
              <p>Physical and occupational therapy evaluation to develop interventions based on the distribution and extent of weakness</p>
            </list-item>
            <list-item>
              <p>Speech evaluation, especially if dysarthria or hypernasal speech is present</p>
            </list-item>
            <list-item>
              <p>Orthodontic evaluation for palatal anomalies</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="mmd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Treatment is aimed at prevention of disease manifestations, early diagnosis by regular screening, and aggressive management of complications that may develop. Effective treatment requires a multidisciplinary approach that can improve both quality of life and survival for the affected individual.</p>
          <p>Ongoing careful assessment of the potential need for part-time or permanent respiratory support is absolutely critical, as affected individuals may rapidly enter respiratory crisis or may unknowingly suffer from potentially fatal nocturnal hypoventilation.</p>
          <p>Feeding support with tube/gavage feeds is needed if oral intake is poor. Failure to thrive may need to be overcome with high-caloric density formulas/feeds. Gastroesophageal reflux (if present) is treated in the usual manner.</p>
          <p>Physical and occupational therapy may help to improve/maintain gross motor and fine motor functions.</p>
          <p>Speech therapy should be provided for individuals with dysarthria/hypernasal speech.</p>
        </sec>
        <sec id="mmd.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Annual influenza and other respiratory infection-related immunizations are advised.</p>
          <p>Aggressive treatment of lower respiratory infections is critical.</p>
        </sec>
        <sec id="mmd.Surveillance">
          <title>Surveillance</title>
          <p>Monitoring for potential complications that can influence the prognosis of MmD includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Frequent and regular monitoring of the spine particularly during childhood and adolescence when scoliosis can rapidly progress during the adolescent growth spurt</p>
            </list-item>
            <list-item>
              <p>Careful monitoring of respiratory function from an early stage because of the risk for insidious nocturnal hypoxia and sudden respiratory failure. Monitoring of respiratory function should include the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Close attention to nocturnal hypoventilation symptoms including early morning headaches, daytime drowsiness, loss of appetite, and deteriorating school performance</p>
                </list-item>
                <list-item>
                  <p>Lung function tests (FEV1 and FVC)</p>
                </list-item>
                <list-item>
                  <p>Sleep studies</p>
                </list-item>
                <list-item>
                  <p>Assessment of the need for intermittent or permanent ventilation. Nocturnal ventilation, when indicated, may significantly improve the prognosis.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Assessment of cardiac status because of the risk of cardiac impairment secondary to respiratory involvement</p>
            </list-item>
          </list>
          <p>Growth should be assessed regularly.</p>
          <p>Regular neuromuscular evaluation to assess disease progress is indicated.</p>
        </sec>
        <sec id="mmd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p><bold>Risk for malignant hyperthermia.</bold> Depolarizing muscle relaxants (e.g., succinylcholine) and inhalational agents (e.g., halothane, isoflurane, desflurane) can cause malignant hyperthermia and therefore need to be avoided during surgical procedures/childbirth, as <italic toggle="yes">RYR1</italic> pathogenic variants are associated with both <related-object link-type="booklink" source-id="gene" document-id="mhs" document-type="chapter">malignant hyperthermia susceptibility</related-object> and MmD.</p>
        </sec>
        <sec id="mmd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="mmd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mmd.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>In women with MmD, there is risk for malignant hyperthermia during delivery if inhalational anesthetic agents are used. A woman who has a fetus affected by MmD may develop polyhydramnios during pregnancy and may report a history of poor fetal movements. Abnormal presentation of an affected fetus may complicate delivery.</p>
        </sec>
        <sec id="mmd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="mmd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mmd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Multiminicore disease (MmD) is most often inherited in an autosomal recessive manner [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2000.745">Ferreiro et al 2000</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2002.284">Jungbluth et al 2002</xref>]. The occurrence of MmD in two generations in a few families has been reported, suggestive of autosomal dominant inheritance.</p>
          <p>Note: Monoallelic expression of just the mutated allele in skeletal muscle has been seen in some persons heterozygous at the genomic DNA level for recessive <italic toggle="yes">RYR1</italic> pathogenic variants [<xref ref-type="bibr" rid="mmd.REF.zhou.2006.859">Zhou et al 2006</xref>].</p>
        </sec>
        <sec id="mmd.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry one mutant allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Carriers (heterozygotes) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of a proband with MmD are obligate carriers (heterozygotes) for the mutant allele causing MmD.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="mmd.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible once the pathogenic variants in the family have been identified.</p>
        </sec>
        <sec id="mmd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Occurrence in more than one generation.</bold> In a few families, occurrence in two generations has been reported. Whether this situation represents autosomal dominant inheritance or "pseudodominant inheritance" of an autosomal recessive disorder is unclear. To establish that a disorder is inherited in an autosomal dominant manner, transmission through a minimum of three generations and/or the presence of heterozygous pathogenic variants is required; it is not clear that MmD has met these criteria.</p>
          <p>Note: Pseudodominant inheritance is more likely to occur in autosomal recessive disorders with a high carrier frequency (e.g., in populations/families with high rates of consanguinity).</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mmd.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SELENON</italic> or <italic toggle="yes">RYR1</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for MmD are possible.</p>
        </sec>
      </sec>
      <sec id="mmd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mmd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="mmd.SELENON_SEPN1_1">
          <title><italic toggle="yes">SELENON</italic> (<italic toggle="yes">SEPN1</italic>)</title>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">SELENON</italic> has 13 exons spanning 18.5 kb. The transcription product is 4.5 kb and the open reading frame has 1770 nucleotides. The functional transcript has one in-frame TGA codon in exon 10, which is read as selenocysteine because of the presence of a selenocysteine insertion sequence (SECIS) element in the 3' UTR region. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mmd" object-id="mmd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign variants.</bold> Known non-pathogenic polymorphisms are included in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf).</p>
          <p><bold>Pathogenic variants.</bold> The pathogenic variants in <italic toggle="yes">SELENON</italic> associated with MmD are summarized in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf) [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2002a.750">Ferreiro et al 2002a</xref>, <xref ref-type="bibr" rid="mmd.REF.ferreiro.2002b.739">Ferreiro et al 2002b</xref>, <xref ref-type="bibr" rid="mmd.REF.tajsharghi.2005.299">Tajsharghi et al 2005</xref>, <xref ref-type="bibr" rid="mmd.REF.zorzato.2007.14">Zorzato et al 2007</xref>].</p>
          <p>Up to two thirds of pathogenic variants cause premature termination of translation; the remaining pathogenic variants are missense changes. Variants appear to be distributed throughout the gene.</p>
          <p><bold>Normal gene product.</bold> The gene encodes a 590-amino acid protein called selenoprotein N. The function of selenoprotein N is not known, but it is found in virtually all tissues examined by western blot. The protein is expressed in very low levels and most studies require overexpression. An enzymatic function has been hypothesized for selenoprotein N based on protein structure and analogies with other selenoproteins with known function. Most of the selenoproteins identified to date are catalysts either in redox processes or in thyroid hormone processing.</p>
          <p>Selenoprotein N has an EF hand Ca<sup>2+</sup> binding motif similar to that found in proteins like calmodulin, suggesting that Ca<sup>2+</sup> may play a role in Ca homeostasis and/or in modulation of selenoprotein N function.</p>
          <p><bold>Abnormal gene product.</bold> The abnormal gene product either is a truncated protein or may contain a missense amino acid substitution. The functional significance of these abnormal products is unknown. <italic toggle="yes">SELENON</italic> mRNAs associated with frameshift or nonsense variants may be resistant to nonsense-mediated decay [<xref ref-type="bibr" rid="mmd.REF.okamoto.2006.175">Okamoto et al 2006</xref>].</p>
        </sec>
        <sec id="mmd.RYR1_1">
          <title>
            <italic toggle="yes">RYR1</italic>
          </title>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">RYR1</italic> has 106 exons encompassing a total of 160 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mmd" object-id="mmd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> More than 25 missense dominant variants in <italic toggle="yes">RYR1</italic> have been associated with <related-object link-type="booklink" source-id="gene" document-id="mhs" document-type="chapter">malignant hyperthermia susceptibility</related-object> and/or <related-object link-type="booklink" source-id="gene" document-id="cco" document-type="chapter">central core disease</related-object> [<xref ref-type="bibr" rid="mmd.REF.galli.2002">Galli et al 2002</xref>]. Pathogenic variants in <italic toggle="yes">RYR1</italic> associated with MmD described to date have been homozygous (see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">Table 4</inline-supplementary-material> [pdf]) [<xref ref-type="bibr" rid="mmd.REF.ferreiro.2002a.750">Ferreiro et al 2002a</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2002.284">Jungbluth et al 2002</xref>, <xref ref-type="bibr" rid="mmd.REF.jungbluth.2005.1930">Jungbluth et al 2005</xref>, <xref ref-type="bibr" rid="mmd.REF.zhou.2007.2024">Zhou et al 2007</xref>, <xref ref-type="bibr" rid="mmd.REF.zorzato.2007.14">Zorzato et al 2007</xref>].</p>
          <p><xref ref-type="bibr" rid="mmd.REF.zhou.2006.859">Zhou et al [2006]</xref> found that <italic toggle="yes">RYR1</italic> undergoes polymorphic, tissue-specific, and developmentally regulated allele silencing, and this unveils recessive pathogenic variants in individuals with core myopathies.</p>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">RYR1</italic> encodes ryanodine receptor 1, the calcium release channel of skeletal muscle sarcoplasmic reticulum. Ryanodine receptor 1 is one of the largest known proteins, with 5038 amino acids. The functional channel is composed of four identical subunits of 565 kd each and has been shown to interact with a number of regulatory proteins. The first 4000 amino acids comprise the hydrophilic cytoplasmic domain that bridges the gap between the transverse tubules and sarcoplasmic reticulum; the last 1000 amino acids form the hydrophobic membrane-spanning plate containing the pore [<xref ref-type="bibr" rid="mmd.REF.tilgen.2001.2879">Tilgen et al 2001</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Most <italic toggle="yes">RYR1</italic> pathogenic variants associated with malignant hyperthermia (MH) and central core disease (CCD) affect calcium homeostasis by either making the calcium channels hypersensitive to activation (associated with MH) or decreasing the amount of calcium released after activation (CCD phenotype) [<xref ref-type="bibr" rid="mmd.REF.dulhunty.2006.351">Dulhunty et al 2006</xref>]. Studies on <italic toggle="yes">RYR1</italic> pathogenic variants associated with MmD phenotype have shown variable dysregulation of calcium homeostasis. While the p.Pro3527Ser variant caused decreased calcium release after stimulation, there was no reduction in the case of the p.Ser71Tyr variant, and increased calcium release was noted with the <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">p.Asn2283His</inline-supplementary-material> variant. One hypothesis is that these pathogenic variants cause instability of the ryanodine receptor macromolecular complex leading to altered binding of regulatory proteins. In contrast, the pathogenic variants <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">p.Arg109Trp</inline-supplementary-material> and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">p.Met485Val</inline-supplementary-material> and the <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mmd-Tables2-4.pdf" content-type="local-data">14646+2.99 kb</inline-supplementary-material> intronic splicing variant are associated with very low endogenous ryanodine receptor protein levels [<xref ref-type="bibr" rid="mmd.REF.ducreux.2006.259">Ducreux et al 2006</xref>, <xref ref-type="bibr" rid="mmd.REF.zorzato.2007.14">Zorzato et al 2007</xref>].</p>
        </sec>
      </sec>
      <sec id="mmd.References">
        <title>References</title>
        <sec id="mmd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mmd.Literature_Cited.reflist0">
            <ref id="mmd.REF.agrawal.2007.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Agrawal</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenleaf</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomczak</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehtokari</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallefeld</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darras</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maciver</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dormitzer</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <article-title>Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2007</year>
                <volume>80</volume>
                <fpage>162</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17160903</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.b_nnemann.2003.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Ven</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warlo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vollmers</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herms</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gautel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>F&#x000fc;rst</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunkel</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle.</article-title>
                <source>J Neurol Sci.</source>
                <year>2003</year>
                <volume>206</volume>
                <fpage>71</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12480088</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.clarke.2006.546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kidson</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quijano-Roy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estournet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manson</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornberg</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>KN</given-names>
                  </name>
                </person-group>
                <article-title>SEPN1: associated with congenital fiber-type disproportion and insulin resistance.</article-title>
                <source>Ann Neurol.</source>
                <year>2006</year>
                <volume>59</volume>
                <fpage>546</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16365872</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.clarke.2010.e1544">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waddell</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornberg</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guglieri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marty</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>KN</given-names>
                  </name>
                </person-group>
                <article-title>Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion.</article-title>
                <source>Hum Mutat.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>E1544</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">20583297</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.cullup.2012.1096">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cullup</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamont</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damian</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallefeld</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gooding</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheehan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2012</year>
                <volume>22</volume>
                <fpage>1096</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">22784669</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.ducreux.2006.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ducreux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorzato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treves</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes.</article-title>
                <source>Biochem J.</source>
                <year>2006</year>
                <volume>395</volume>
                <fpage>259</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">16372898</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.dulhunty.2006.351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dulhunty</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beard</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouliquin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies.</article-title>
                <source>J Muscle Res Cell Motil.</source>
                <year>2006</year>
                <volume>27</volume>
                <fpage>351</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">16909197</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.ferreiro.2004.676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick-de Groote</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goemans</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <article-title>Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene.</article-title>
                <source>Ann Neurol.</source>
                <year>2004</year>
                <volume>55</volume>
                <fpage>676</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">15122708</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.ferreiro.2000.745">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estournet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chateau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laroche</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>dos Santos</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haenggeli</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Multi-minicore disease--searching for boundaries: phenotype analysis of 38 cases.</article-title>
                <source>Ann Neurol.</source>
                <year>2000</year>
                <volume>48</volume>
                <fpage>745</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">11079538</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.ferreiro.2002.60">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>80th ENMC International Workshop on Multi-Minicore Disease: 1st International MmD Workshop. 12-13th May, 2000, Soestduinen, The Netherlands.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2002</year>
                <volume>12</volume>
                <fpage>60</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11731287</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.ferreiro.2002a.750">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haenggeli</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voss</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivoche</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemainque</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.</article-title>
                <source>Ann Neurol.</source>
                <year>2002a</year>
                <volume>51</volume>
                <fpage>750</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12112081</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.ferreiro.2002b.739">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quijano-Roy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pichereau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moghadaszadeh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goemans</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villanova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estournet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2002b</year>
                <volume>71</volume>
                <fpage>739</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">12192640</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.fischer.2002.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matten</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Expression, localization and functional divergence of alphaB-crystallin and heat shock protein 27 in core myopathies and neurogenic atrophy.</article-title>
                <source>Acta Neuropathol.</source>
                <year>2002</year>
                <volume>104</volume>
                <fpage>297</fpage>
                <lpage>304</lpage>
                <pub-id pub-id-type="pmid">12172916</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.galli.2002">
              <mixed-citation publication-type="other">Galli L, Orrico A, Cozzolino S, Pietrini V, Tegazzin V, Sorrentino V. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region. ll Calcium. 2002;32:143-51.</mixed-citation>
            </ref>
            <ref id="mmd.REF.gommans.2003.1545">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gommans</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lammens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastaglia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamont</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijnhoven</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>ter Laak</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogels</surname>
                    <given-names>OJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremer</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions.</article-title>
                <source>Brain.</source>
                <year>2003</year>
                <volume>126</volume>
                <fpage>1545</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">12805120</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.guis.2004.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figarella-Branger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bendahan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozak-Ribbens</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattei</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cozzone</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellissier</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <article-title>Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization.</article-title>
                <source>Arch Neurol.</source>
                <year>2004</year>
                <volume>61</volume>
                <fpage>106</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">14732627</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.jungbluth.2002.284">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliger-Keller</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockington</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chattopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roper</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bydder</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores.</article-title>
                <source>Neurology.</source>
                <year>2002</year>
                <volume>59</volume>
                <fpage>284</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12136074</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.jungbluth.2000.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Minicore myopathy in children: a clinical and histopathological study of 19 cases.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2000</year>
                <volume>10</volume>
                <fpage>264</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">10838253</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.jungbluth.2001.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowak</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2001</year>
                <volume>11</volume>
                <fpage>35</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">11166164</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.jungbluth.2005.1930">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartley</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliger-Keller</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockington</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swash</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bydder</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.</article-title>
                <source>Neurology.</source>
                <year>2005</year>
                <volume>65</volume>
                <fpage>1930</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16380615</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.kaindl.2004.842">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaindl</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000fc;schendorf</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koehler</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pongratz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-H&#x000f6;cker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoltenburg-Didinger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Missense mutations of ACTA1 cause dominant congenital myopathy with cores.</article-title>
                <source>J Med Genet.</source>
                <year>2004</year>
                <volume>41</volume>
                <fpage>842</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15520409</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.lillis.2012">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lillis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Multi-minicore disease.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2012</year>
                <month>Feb</month>
                <volume>20</volume>
                <issue>2</issue>
                <comment/>
                <pub-id pub-id-type="doi">10.1038/ejhg.2011.180</pub-id>
                <pub-id pub-id-type="pmid">22009146</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.moghadaszadeh.2001.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moghadaszadeh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petit</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaillard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockington</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quijano Roy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estournet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desguerre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaigne</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome.</article-title>
                <source>Nat Genet.</source>
                <year>2001</year>
                <volume>29</volume>
                <fpage>17</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11528383</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.monnier.2003.1171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marty</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labarre-Vila</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mezin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunardi</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2003</year>
                <volume>12</volume>
                <fpage>1171</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12719381</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.monnier.2008.670">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marty</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castiglioni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnuelle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estournet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laquerriere</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazaro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van der Kooi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschuuren</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunardi</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores.</article-title>
                <source>Hum Mutat.</source>
                <year>2008</year>
                <volume>29</volume>
                <fpage>670</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18253926</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.monnier.2001.2581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerale</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landrieu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivoche</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunardi</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2001</year>
                <volume>10</volume>
                <fpage>2581</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11709545</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.nadajpakleza.2007.56">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nadaj-Pakleza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fidzia&#x00144;ska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryniewicz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kostera-Pruszczyk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreiro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwieci&#x00144;ski</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kami&#x00144;ska</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Multi-minicore myopathy: a clinical and histopathological study of 17 cases.</article-title>
                <source>Folia Neuropathol.</source>
                <year>2007</year>
                <volume>45</volume>
                <fpage>56</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">17594595</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.okamoto.2006.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takashima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuyama</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suehara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishihira</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashiguchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arimura</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Molecular mechanism of rigid spine with muscular dystrophy type 1 caused by novel mutations of selenoprotein N gene.</article-title>
                <source>Neurogenetics.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>175</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">16779558</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.scacheri.2000.1689">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scacheri</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fratkin</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semino-Mora</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senchak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vedanarayanan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subramony</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy.</article-title>
                <source>Neurology.</source>
                <year>2000</year>
                <volume>55</volume>
                <fpage>1689</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">11113224</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.tajsharghi.2005.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tajsharghi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulinius</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Early onset myopathy with a novel mutation in the Selenoprotein N gene (SEPN1).</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2005</year>
                <volume>15</volume>
                <fpage>299</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">15792869</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.tilgen.2001.2879">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tilgen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorzato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliger-Keller</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmucci</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann-Horn</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treves</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2001</year>
                <volume>10</volume>
                <fpage>2879</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">11741831</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.wilmshurst.2010.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilmshurst</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillay</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ndondo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cloke</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cullup</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boennemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinlivan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sarraj</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treves</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>RYR1 mutations are a common cause of congenital myopathies with central nuclei.</article-title>
                <source>Ann Neurol.</source>
                <year>2010</year>
                <volume>68</volume>
                <fpage>717</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">20839240</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.wu.2006.1470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ibarra</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malicdan</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichihara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikuchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Central core disease is due to RYR1 mutations in more than 90% of patients.</article-title>
                <source>Brain.</source>
                <year>2006</year>
                <volume>129</volume>
                <fpage>1470</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16621918</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.zhou.2006.859">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockington</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2006</year>
                <volume>79</volume>
                <fpage>859</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">17033962</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.zhou.2007.2024">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roper</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockington</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleton</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinlivan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swash</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treves</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.</article-title>
                <source>Brain.</source>
                <year>2007</year>
                <volume>130</volume>
                <fpage>2024</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">17483490</pub-id>
              </element-citation>
            </ref>
            <ref id="mmd.REF.zorzato.2007.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zorzato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treves</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Functional effects of mutations identified in patients with multiminicore disease.</article-title>
                <source>IUBMB Life.</source>
                <year>2007</year>
                <volume>59</volume>
                <fpage>14</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">17365175</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mmd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mmd.Author_Notes">
          <title>Author Notes</title>
          <p>Web page: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.childrenshospital.org">www.childrenshospital.org</ext-link></p>
        </sec>
        <sec id="mmd.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors gratefully acknowledge generous support by the Lee and Penny Anderson Family Foundation and the Muscular Dystrophy Association (USA) for ongoing research on multiminicore disease.</p>
        </sec>
        <sec id="mmd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>24 January 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 April 2008 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 January 2006 (cd) Revision: <italic toggle="yes">RYR1</italic> mutation testing clinically available; <italic toggle="yes">SEPN1</italic> mutation testing available through custom laboratories</p>
            </list-item>
            <list-item>
              <p>26 July 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>25 March 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>6 December 2002 (ab) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
